Slide 1: Exchange filing cover letter
Date : 14 th November, 2025 To, National Stock Exchange of India – Emerge Platform Mumbai Scrip Code : APRAMEYA ISIN : INE0LQG01010 Sub.: H1 Earnings Call for the Period ended on 30th September, 2025 Most Respectfully, Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirement
Slide 2: Investor Presentation H1FY26
INVESTOR PRESENTATION H1FY26
Slide 3: Table of Content
Table of Content H1FY26 Company Performance Overview Key Business Historical Strengths Financials 2
Slide 4: H1FY26 Performance
H1FY26 Performance 3
Slide 5: Management's Commentary
Management’s Commentary We delivered healthy revenue growth and maintained stable margins in the first half, supported by strong execution and a robust order book. In October, we entered medical device manufacturing through our subsidiary, Aprameya Medtech Private Limited, launching HystroPress, a F
Slide 6: Driving Growth, Strengthening Foundations – H1FY26
Driving Growth, Strengthening Foundations – H1FY26 Total Revenue EBITDA & Margin (%) PAT & Margin (%) Revenue Mix (%) 12% Rs 423 Mn Rs 112 Mn Rs 68 Mn Turnkey Project Supply 343% YoY 1,123% YoY 492% YoY Medical Equipment Margin 26% Margin 16% Solutions 88% Business Update • Executed Modular OT
Slide 7: Profit & Loss Statement
Profit & Loss Statement Particulars (Rs Mn) H1FY26 H1FY25 YoY % FY25 FY24 YoY % Revenue From Operations 421.4 92.7 1,357.1 651.6 Other Income 1.9 2.8 5.9 4.6 Total Income 423.3 95.5 343% 1,363.0 656.2 108% Purchase of Stock in trade 56.0 25.5 71.3 122.8 Turnkey Project Expenses 154.6 45.3 945.2 330.
Slide 8: Aprameya's Strategic Growth Blueprint (1/2)
Aprameya’s Strategic Growth Blueprint (1/2) Growth Roadmap & Market Expansion MedTech Scale-Up & Manufacturing Margin Expansion & Profitability • Targeting 20-25% CAGR over the next 3-year period • Launch 5-6 new MedTech products by FY27 across • Sustain 22-24% EBITDA and 14-16% PAT margins in overa
Slide 9: Aprameya's Strategic Growth Blueprint (2/2)
Aprameya’s Strategic Growth Blueprint (2/2) Recurring Revenue & Installed Base Monetization Integrated Healthcare Platform & Talent Strength Digital, Financial & Risk Excellence • Growing installed base to drive CAMC, • Building a 4-vertical integrated platform: • Deploy AI-driven project scheduling
Slide 10: Aprameya Engineering Enters the Medical Device Manufacturing Space
Aprameya Engineering Enters the Medical Device Manufacturing Space Company Overview: Application: • New subsidiary: Aprameya Medtech Private Limited • Used in hysteroscopy for IVF & gynecology • Strategic move to bridge the gap between imported and domestic devices • Controls uterine cavity distensi
Slide 11: Positive Industry Outlook Provides Ample of Opportunities
Positive Industry Outlook Provides Ample of Opportunities India’s Healthcare Infrastructure: Current Landscape Indian Medical Device Market (USD Bn) • Significant demand-supply gap – India has 2 million hospital beds, far below the 4.9 million recommended by WHO. 50.0 • Low Bed Density – India has 1
Slide 12: Company Overview
Company Overview 11
Slide 13: Journey from a Medical Equipment Supplier to handling Turnkey Projects
Journey from a Medical Equipment Supplier to handling Turnkey Projects… Established in 2003, Aprameya Engineering specializes in setting up and maintaining ICUs, NICUs, PICUs, Operation Theatres, Aprameya at a Glance Dialysis Centers, and Prefabricated Wards on a turnkey basis for private and govern
Slide 14: Offering One-Stop Solutions for Healthcare Infrastructure Development
…Offering One-Stop Solutions for Healthcare Infrastructure Development Typical Business Process Project Identification Pre-Qualification Bid Submission Award of the Contract Healthcare Medical Equipment Service & CAMC* Site Allocation & Site Visit Infrastructure Projects Solutions Solutions (90%)^ (
Slide 15: Healthcare Infrastructure Project (1/2)
1. Healthcare Infrastructure Project (1/2) Hospital Design Solution We provide Hospital Design Solutions, integrating architecture, structural, MEP, and interior design for efficient, patient-centric, and high-tech healthcare spaces. Architecture Design: Structural Design: Optimized layouts, Robust
Slide 16: Healthcare Infrastructure Project (2/2)
1. Healthcare Infrastructure Project (2/2) Turnkey Healthcare Solutions We provide Turnkey Healthcare Solutions, including MOT, ICU, NICU, CCU, Prefab Healthcare Facilities, and Specialty Centers, integrating advanced medical equipment, precision ventilation, soundproofing, and fire-resistant struct
Slide 17: Medical Equipment Solutions
2. Medical Equipment Solutions We offer a wide range of Medical Equipments across varied specialties, along with Equipment Planning & SITC (Supply, Installation, Testing, Commissioning) Solutions. Cardiology Neurology Anesthesiology Nephrology Biochemistry Radiology Surgery Home Care Product Product
Slide 18: Service and CAMC Solutions
3. Service and CAMC Solutions • We provide Service & CAMC* Solutions, offering complete maintenance and support for Turnkey Projects and Medical Equipment to ensure reliability and efficiency • Our CAMC solutions ensure reliable, compliant, and efficient operation of ICU, NICU, OT, imaging, and diag
Slide 19: Leadership Driving Our Success
Leadership Driving Our Success Saurabh Bhatt Chairman & Joint Managing Director Pooja Bhatt Archana Joshi Non-Executive Non-Executive Director Director • Qualification: Bachelor of Engineering (Industrial Electronics), Diploma in Industrial Electronics • Experience: 20+ years • Responsible for the o
Slide 20: Our Competitive Edge
Our Competitive Edge 19
Slide 21: Our Competitive Edge
Our Competitive Edge Innovative and Strong Relationships Turnkey Project Proven Execution Integrated with Suppliers and One-Stop Solution Track Record Healthcare Solutions Clients Faster project turnaround, Diverse range of products Strong ties with top manufacturers Successful large-scale single-ve
Slide 22: Turnkey Project – One-Stop Solution
Turnkey Project – One-Stop Solution Traditional Challenges in Hospital Infrastructure Development… • Hospitals typically issue separate tenders for infrastructure, equipment, and specialized facilities, leading to delays, higher costs, and execution challenges. • Coordinating multiple vendors increa
Slide 23: Leading with Innovative and Integrated Solutions
Leading with Innovative and Integrated Solutions Mobile CT Scan Mobile Stroke Unit (MSU) EP Lab (Smart Ablate, Carto 3, and 2D EP Tracer) A compact, portable CT imaging system installed in mobile A specially equipped ambulance with onboard CT scanner, An advanced Electrophysiology Lab combining Cart
Slide 24: Introducing - Surgical Soft Tissue Robot
Introducing - Surgical Soft Tissue Robot Key Advantages Sharper Vision Precise Control Surgeon Comfort 3D–4K imaging provides a Flexible, hand-like Ergonomic design reduces clear, detailed view instruments for safe surgery strain and tremors High Accuracy Collaboration Smooth Workflow Motion scaling
Slide 25: Strong Industry Partnerships
Strong Industry Partnerships (Collaborations that drive success) We ensure hospitals receive best-in-class medical equipment through authorized distributorships with Johnson & Johnson Private Limited, Schiller Healthcare India Pvt. Ltd, Phillips India Ltd, Alan Electronics Systems Pvt. Ltd, & ResMed
Slide 26: Long Standing Relationships with Clientele
Long Standing Relationships with Clientele • Trusted by government institutions like AIIMS and leading public Healthcare Bodies, while also serving Top Private Hospitals, Clientele Diagnostic Centers, and Medical Practitioners. • Private Hospitals • Current presence in the states of Gujarat, Rajasth
Slide 27: Proven Execution Track Record
Proven Execution Track Record Aprameya Engineering has emerged as a trusted leader in turnkey healthcare infrastructure, consistently delivering high-quality projects on time and within budget. Its successful track record includes projects for AIIMS, private healthcare chains, government hospitals,
Slide 28: Some of our Completed Projects (1/2)
Some of our Completed Projects (1/2) Dr. S.N. Medical College, Jodhpur RNT Medical College, Udaipur Before After Scope of Work 120 ICU beds Site Modification Work 100 beds for roof of MCDW and 100 beds for old OPD Order Value Rs 166 Mn Rs 105 Mn 27
Slide 29: Some of our Completed Projects (2/2)
Some of our Completed Projects (2/2) Rajasthan Medical Services Corporation Limited, Jaipur Rajasthan Medical Services Corporation Limited, Jaipur Before After Scope of Work Establishment of ICU’s on turnkey basis at 45 locations 175 Dialysis Centers (Turnkey Basis) Order Value Rs 280 Mn Rs 314 Mn 2
Slide 30: Media Highlights of Our Projects and Achievements
Media Highlights of Our Projects and Achievements 29
Slide 31: Historical Financials
Historical Financials 30
Slide 32: Robust Financial Growth with ~100% YoY Increase in FY25
Robust Financial Growth with ~100% YoY Increase in FY25 Total Revenue (Rs Mn) EBITDA (Rs Mn) & Margin (%) PAT (Rs Mn) & Margin (%) Covid-19 Impact State and 18% 12% Central 8% 13% 12% 7% 5% Elections 10% 4% 2,000 10% Impact 249 251 1,363 166 161 781 652 259 97 25 68 10 54 35 FY21 FY22 FY23 FY24 FY25
Slide 33: Profit & Loss Highlights
Profit & Loss Highlights Particulars (Rs Mn) FY21 FY22 FY23 FY24 FY25 H1FY26 Revenue From Operations 259.3 1,999.9 781.2 651.6 1,357.1 421.4 Other Income 0.8 2.7 2.1 4.6 5.9 1.9 Total Income 260.1 2,002.6 783.3 656.2 1,363.0 423.3 Purchase of Stock in trade 93.0 680.5 80.9 122.8 71.3 56.0 Turnkey Pr
Slide 34: Balance Sheet Highlights
Balance Sheet Highlights Liabilities (Rs Mn) Mar - 22 Mar - 23 Mar - 24 Mar - 25 Sep - 25 Assets (Rs Mn) Mar - 22 Mar - 23 Mar - 24 Mar - 25 Sep - 25 Share Capital 70.0 140.0 140.0 190.4 190.4 Property, Plant & Equipment 15.3 14.6 14.3 13.8 13.4 & Intangible Assets Reserves & Surplus 75.3 59.3 94.0
Slide 35: Cash Flow Highlights
Cash Flow Highlights Particulars (Rs Mn) FY22 FY23 FY24 FY25 H1FY26 (A) Net Cash Flow from Operating Activities -3.7 -135.0 -99.8 -106.4 -45.4 (B) Net Cash Flow from Investing Activities -26.5 -18.3 -10.0 -4.1 -12.1 (C) Net Cash Flow from Financing Activities 55.3 130.4 111.1 108.9 56.4 Net (Decreas
Slide 36: Stock Information
Stock Information Shareholding Pattern (as on 30 September 2025) Script Related Information (as on 13th November 2025) BSE/NSE Code NSE - SME: APRAMEYA Public 25.7% Promoters 73.5% CMP (Rs) 262.55 DII Market Cap (Rs Cr) 241 0.8% Shares O/s (Cr) 1.90 Face Value (Rs) 10 Promoters DII Public Average Tr
Slide 37: Investor Relations contacts
CIN No. U51909GJ2021PLC128294 Investor Relations Jignesh Suthar, CFO Pooja Sharma| Akhilesh Gandhi, CFA aprameyaengg@aelhealth.com pooja.sharma@stellar-ir.com | akhilesh@stellar-ir.com Phone: +91 - 9724655002 Phone: +91 22 62398024